You are being treated with one of the SGLT2 inhibitors medicines, sometimes known as ‘gliflozins’ or ‘flozins’. These include: canagliflozin (Invokana®), dapagliflozin (Forxiga®), empaglaflozin (Jardiance®) and ertugiflozin (Steglatro®).
These medicines were initially developed to treat people with diabetes as they lower blood glucose by increasing the amount of glucose in the urine. They have added benefits that include protecting the kidneys and heart, slowing the decline in kidney function and reducing the risk of heart failure and heart attacks in individuals at most risk.
These kidney and heart benefits apply to all individuals, not just those with diabetes.
It is best practice to use good sick day guidance with these medicines. You should stop taking SGLT2 inhibitors if unwell especially with vomiting, diarrhoea or fever (high temperature) or if you are fasting e.g. before an operation. You can re-start them when you are better or as advised by a health professional.
Quayside Medical Practice
Keppel Building, Ashton Road West, Failsworth, Manchester, M35 0AD.
Tel: 0161 357 1600
Copyright © 2023 Quayside Medical Practice - All Rights Reserved.